These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 21274004

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression.
    Dhingra K, Talpaz M, Kantarjian H, Ku S, Rothberg J, Gutterman JU, Kurzrock R.
    Leukemia; 1991 Mar; 5(3):191-5. PubMed ID: 2013978
    [Abstract] [Full Text] [Related]

  • 23. Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia.
    Pullarkat ST, Vardiman JW, Slovak ML, Rao DS, Rao NP, Bedell V, Said JW.
    Leuk Res; 2008 Nov; 32(11):1770-5. PubMed ID: 18417213
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
    Fujie H, Tsuchiya S, Morita S, Itano M, Yambe T, Ohasi Y, Minegishi N, Minegishi M, Satou T, Konno T.
    Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
    Neubauer A, He M, Schmidt CA, Huhn D, Liu ET.
    Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238
    [Abstract] [Full Text] [Related]

  • 28. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M.
    N Engl J Med; 2001 Apr 05; 344(14):1038-42. PubMed ID: 11287973
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Phenotypic and gene expression diversity of malignant cells in human blast crisis chronic myeloid leukemia.
    Simanovsky M, Berlinsky S, Sinai P, Leiba M, Nagler A, Galski H.
    Differentiation; 2008 Oct 05; 76(8):908-22. PubMed ID: 18452548
    [Abstract] [Full Text] [Related]

  • 31. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M.
    Hokkaido Igaku Zasshi; 1993 Mar 05; 68(2):237-50. PubMed ID: 8509066
    [Abstract] [Full Text] [Related]

  • 32. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
    Melo JV, Goldman JM.
    Leukemia; 1992 Aug 05; 6(8):786-90. PubMed ID: 1353550
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses.
    Adnan Awad S, Dufva O, Ianevski A, Ghimire B, Koski J, Maliniemi P, Thomson D, Schreiber A, Heckman CA, Koskenvesa P, Korhonen M, Porkka K, Branford S, Aittokallio T, Kankainen M, Mustjoki S.
    Leukemia; 2021 Apr 05; 35(4):1087-1099. PubMed ID: 32782381
    [Abstract] [Full Text] [Related]

  • 37. Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis.
    Raanani P, Trakhtenbrot L, Rechavi G, Rosenthal E, Avigdor A, Brok-Simoni F, Leiba M, Amariglio N, Nagler A, Ben-Bassat I.
    Acta Haematol; 2005 Apr 05; 113(3):181-9. PubMed ID: 15870488
    [Abstract] [Full Text] [Related]

  • 38. AID expression is correlated with Bcr-Abl expression in CML-LBC and can be down-regulated by As2O3 and/or imatinib.
    Liu Z, Wu X, Duan Y, Wang Y, Shan B, Kong J, Ma X, Bao Y.
    Leuk Res; 2011 Oct 05; 35(10):1355-9. PubMed ID: 21570118
    [Abstract] [Full Text] [Related]

  • 39. The onset of CML in blastic crisis: molecular features.
    Gregorini A, Filippetti A, Luchetti F, Walker A, Lillington DM, Papa S, Valentini M.
    J Biol Regul Homeost Agents; 1997 Oct 05; 11(3):111-4. PubMed ID: 9498160
    [Abstract] [Full Text] [Related]

  • 40. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S, Cruz M, Rabelo L, Godínez R, Reyes-Maldonado E, Riebeling-Navarro C.
    Eur J Haematol; 2004 Apr 05; 72(4):231-8. PubMed ID: 15089759
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.